title: Whither thromboprophylaxis after total hip replacement?
authors.affiliation: National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.
authors.forename: D P
authors.initials: DP
authors.lastname: Thomas
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip / Q000639:trends*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication / Q000639:trends; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000235:genetics / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000639:trends*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents